Dual Mobility Implants for Hip Dislocation
What You Need to Know Before You Apply
What is the purpose of this trial?
The aim of this study is to compare clinical outcomes of patients considered to be high risk for prosthetic dislocation undergoing primary total hip arthroplasty (THA) with the use of a dual mobility bearing versus a conventional, single bearing design.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is the dual mobility implant generally safe for humans?
How does the dual mobility implant treatment differ from other treatments for hip dislocation?
The dual mobility implant is unique because it features a design with a small femoral head that moves within a larger polyethylene insert, which then moves within an outer shell. This design helps reduce the risk of hip dislocation compared to traditional single-bearing hip implants, making it particularly beneficial for patients at high risk of dislocation.12356
What data supports the effectiveness of dual mobility implants for hip dislocation?
Research shows that dual mobility cups (DMCs) significantly reduce the rate of hip dislocation in both primary and revision total hip arthroplasties (THAs). They are especially beneficial for patients at high risk of dislocation, offering a greater range of motion and stability compared to traditional hip implants.12347
Are You a Good Fit for This Trial?
This trial is for adults over 75, or those with a history of lumbar fusion surgery, neuromuscular disorders, cognitive impairments, substance abuse, hip fractures, or inflammatory arthritis. It's not for people under 18 or those who've had previous hip surgeries other than lumbar fusion at least 6 months ago.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo primary total hip arthroplasty (THA) with either a dual mobility bearing or a conventional single-bearing design
Follow-up
Participants are monitored for safety and effectiveness, including radiographic assessments and monitoring for complications
What Are the Treatments Tested in This Trial?
Interventions
- Dual mobility implant
- Traditional, Single-bearing hip implant
Dual mobility implant is already approved in European Union, United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor
Keck School of Medicine of USC
Collaborator
Rothman Institute Orthopaedics
Collaborator
Keck School of Medicine of USC
Collaborator
New York University
Collaborator